Literature DB >> 19762559

Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference.

Alexander Heinick1, Katja Urban, Stefan Roth, Danica Spies, Frank Nunes, Otto Phanstiel, Eva Liebau, Kai Lüersen.   

Abstract

Physiological polyamines are required in various biological processes. In the current study, we used norspermidine, a structural analog of the natural polyamine spermidine, to investigate polyamine uptake in the model organism Caenorhabditis elegans. Norspermidine was found to have two remarkable effects: it is toxic for the nematode, without affecting its food, Escherichia coli; and it hampers RNA interference. By characterizing a norspermidine-resistant C. elegans mutant strain that has been isolated in a genetic screen, we demonstrate that both effects, as well as the uptake of a fluorescent polyamine-conjugate, depend on the transporter protein CATP-5, a novel P(5B)-type ATPase. To our knowledge, CATP-5 represents the first P(5)-type ATPase that is associated with the plasma membrane, being expressed in the apical membrane of intestinal cells and the excretory cell. Moreover, genetic interaction studies using C. elegans polyamine synthesis mutants indicate that CATP-5 has a function redundant to polyamine synthesis and link reduced polyamine levels to retarded postembryonic development, reduced brood size, shortened life span, and small body size. We suggest that CATP-5 represents a crucial component of the pharmacologically important polyamine transport system, the molecular nature of which has not been identified so far in metazoa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762559      PMCID: PMC2797033          DOI: 10.1096/fj.09-135889

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  42 in total

1.  Transport of polyamines in Drosophila S2 cells: kinetics, pharmacology and dependence on the plasma membrane proton gradient.

Authors:  Rafael Romero-Calderón; David E Krantz
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

Review 2.  A biochemist's guide to Caenorhabditis elegans.

Authors:  Ann K Corsi
Journal:  Anal Biochem       Date:  2006-08-11       Impact factor: 3.365

3.  Mechanism of polyamine tolerance in yeast: novel regulators and insights.

Authors:  Z Porat; N Wender; O Erez; C Kahana
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

4.  Polyamine uptake by DUR3 and SAM3 in Saccharomyces cerevisiae.

Authors:  Takeshi Uemura; Keiko Kashiwagi; Kazuei Igarashi
Journal:  J Biol Chem       Date:  2007-01-11       Impact factor: 5.157

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major.

Authors:  Marie-Pierre Hasne; Buddy Ullman
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 7.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.

Authors:  Robert A Casero; Laurence J Marton
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

8.  Structure-activity investigations of polyamine-anthracene conjugates and their uptake via the polyamine transporter.

Authors:  O Phanstiel; N Kaur; J-G Delcros
Journal:  Amino Acids       Date:  2007-04-06       Impact factor: 3.520

Review 9.  Chemistry-to-gene screens in Caenorhabditis elegans.

Authors:  Andrew K Jones; Steven D Buckingham; David B Sattelle
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

10.  C. elegans feeding defective mutants have shorter body lengths and increased autophagy.

Authors:  Catarina Mörck; Marc Pilon
Journal:  BMC Dev Biol       Date:  2006-08-03       Impact factor: 1.978

View more
  16 in total

Review 1.  Recent advances in the molecular biology of metazoan polyamine transport.

Authors:  R Poulin; R A Casero; D Soulet
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 2.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

3.  Polyamine-independent Expression of Caenorhabditis elegans Antizyme.

Authors:  Dirk Stegehake; Marc-André Kurosinski; Sabine Schürmann; Jens Daniel; Kai Lüersen; Eva Liebau
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

4.  ATP13A2 deficiency disrupts lysosomal polyamine export.

Authors:  Sarah van Veen; Shaun Martin; Chris Van den Haute; Veronick Benoy; Joseph Lyons; Roeland Vanhoutte; Jan Pascal Kahler; Jean-Paul Decuypere; Géraldine Gelders; Eric Lambie; Jeffrey Zielich; Johannes V Swinnen; Wim Annaert; Patrizia Agostinis; Bart Ghesquière; Steven Verhelst; Veerle Baekelandt; Jan Eggermont; Peter Vangheluwe
Journal:  Nature       Date:  2020-01-29       Impact factor: 49.962

5.  Structural basis of polyamine transport by human ATP13A2 (PARK9).

Authors:  Sue Im Sim; Sören von Bülow; Gerhard Hummer; Eunyong Park
Journal:  Mol Cell       Date:  2021-10-28       Impact factor: 17.970

6.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

7.  Norspermidine and novel Pd(II) and Pt(II) polynuclear complexes of norspermidine as potential antineoplastic agents against breast cancer.

Authors:  Tânia Magalhães Silva; Sara Andersson; Sunil Kumar Sukumaran; Maria Paula Marques; Lo Persson; Stina Oredsson
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 8.  Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

Authors:  Sarah van Veen; Danny M Sørensen; Tine Holemans; Henrik W Holen; Michael G Palmgren; Peter Vangheluwe
Journal:  Front Mol Neurosci       Date:  2014-05-27       Impact factor: 5.639

9.  Evaluation of Polyamine Transport Inhibitors in a Drosophila Epithelial Model Suggests the Existence of Multiple Transport Systems.

Authors:  Minpei Wang; Otto Phanstiel; Laurence von Kalm
Journal:  Med Sci (Basel)       Date:  2017-11-14

10.  CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter.

Authors:  Eric J Lambie; Pamela J Tieu; Nadja Lebedeva; Diane L Church; Barbara Conradt
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.